Ati cautat: reactii adverse medicamente
Protocol terapeutic: N07XX11 – DCI PITOLISANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX63 – DCI GLASDEGIB (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: A10BD24 – DCI COMBINAȚII ERTUGLIFLOZINUM + SITAGLIPTINUM (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: J02AB02 – DCI KETOCONAZOLUM (comprimate 200 MG) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: B01AC27 – DCI SELEXIPAGUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ06 – DCI SEMAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ01 – DCI EXENATIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
EMA a aprobat doua tratamente pe baza de anticorpi monoclonali
